TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 19 filers reported holding TREVI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,683,214 | -12.3% | 2,148,263 | -3.9% | 0.00% | – |
Q2 2023 | $5,341,318 | +3410.5% | 2,234,861 | +2617.3% | 0.00% | – |
Q1 2023 | $152,154 | -2.4% | 82,245 | +1.8% | 0.00% | – |
Q4 2022 | $155,887 | +73.2% | 80,771 | +37.3% | 0.00% | – |
Q3 2022 | $90,000 | -44.1% | 58,824 | +2.3% | 0.00% | – |
Q2 2022 | $161,000 | +120.5% | 57,494 | +71.9% | 0.00% | – |
Q1 2022 | $73,000 | +108.6% | 33,439 | -25.6% | 0.00% | – |
Q4 2021 | $35,000 | -42.6% | 44,948 | +2.4% | 0.00% | – |
Q3 2021 | $61,000 | -38.4% | 43,899 | -0.6% | 0.00% | – |
Q2 2021 | $99,000 | +13.8% | 44,180 | +36.4% | 0.00% | – |
Q1 2021 | $87,000 | +55.4% | 32,394 | +40.6% | 0.00% | – |
Q4 2020 | $56,000 | -37.1% | 23,037 | +4.2% | 0.00% | – |
Q3 2020 | $89,000 | -42.6% | 22,118 | -6.7% | 0.00% | – |
Q2 2020 | $155,000 | +416.7% | 23,713 | +161.4% | 0.00% | – |
Q1 2020 | $30,000 | +7.1% | 9,072 | +23.4% | 0.00% | – |
Q4 2019 | $28,000 | +460.0% | 7,349 | +531.4% | 0.00% | – |
Q3 2019 | $5,000 | -80.8% | 1,164 | -66.6% | 0.00% | – |
Q2 2019 | $26,000 | – | 3,484 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 1,263,408 | $2,843,000 | 0.32% |
NEA Management Company, LLC | 5,940,796 | $13,367,000 | 0.17% |
TPG Group Holdings (SBS) Advisors, Inc. | 4,824,883 | $10,856,000 | 0.08% |
WealthTrust Axiom LLC | 39,500 | $88,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 34,600 | $78,000 | 0.00% |
BlackRock Inc. | 44,180 | $99,000 | 0.00% |
LPL Financial LLC | 10,000 | $23,000 | 0.00% |
Alberta Investment Management Corp | 25,000 | $56,000 | 0.00% |
Tower Research Capital LLC (TRC) | 4,187 | $10,000 | 0.00% |
Renaissance Technologies | 92,600 | $208,000 | 0.00% |